We performed Western blotting for various isoforms of PI3K p110 in 35 primary serous type ovarian cancer and 5 benign tumor samples to investigate which isoform was significantly overexpressed in this subset of ovarian cancer. This evidence concerns the gene PIK3CA and benign neoplasm.